NT-proBNP: Can We Better Utilize Biomarkers in Patients With Diabetes?

被引：3
|
作者：
Cavender, Matthew A. [1 ]
Scirica, Benjamin M. [2 ,3 ]
机构：
[1] Univ N Carolina, Dept Med, Div Cardiol, Chapel Hill, NC 27515 USA
[2] Brigham & Womens Hosp, Dept Med, Div Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA
[3] Harvard Med Sch, Boston, MA 02115 USA
来源：
DIABETES CARE | 2020年 / 43卷 / 12期
关键词：
NATRIURETIC PEPTIDE; HEART-FAILURE; RISK; IMPACT;
D O I：
10.2337/dci20-0047
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2904 / 2905
页数：2
相关论文
共 50 条
  • [21] A comparison of NT-proBNP and albuminuria for predicting cardiac events in patients with diabetes mellitus
    Clodi, Martin
    Resl, Michael
    Neuhold, Stephanie
    Huelsmann, Martin
    Vila, Greisa
    Elhenicky, Marie
    Strunk, Guido
    Abrahamian, Heidemarie
    Prager, Rudolf
    Luger, Anton
    Pacher, Richard
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2012, 19 (05) : 944 - 951
  • [22] NT-proBNP as a predictor of death and cardiovascular events in patients with type 2 diabetes
    Bolivar Malachias, Marcus Vinicius
    Wijkman, Magnus Olof
    Bertoluci, Marcello Casaccia
    DIABETOLOGY & METABOLIC SYNDROME, 2022, 14 (01):
  • [23] Diabetes as a factor for increased NT-proBNP levels in patients without heart failure
    Francisco Dias Claudio, F.
    Ribeirinho, R.
    Batista, B.
    Sousa, A. C.
    Tribolet De Abreu, T.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 128 - 128
  • [24] Comparison of NT-proBNP and proteinuria as predictors of cardiac events in patients with diabetes mellitus
    Neuhold, S.
    Huelsmann, M.
    Gouya, G.
    Strunk, G.
    Prager, R.
    Abrahamian, H.
    Clodi, M.
    Luger, A.
    Riedl, M.
    Pacher, R.
    EUROPEAN HEART JOURNAL, 2008, 29 : 477 - 478
  • [25] NT-proBNP values in elderly heart failure patients with atrial fibrillation and diabetes
    Taut, Adela Viviana Sitar
    Pop, Dana
    Zdrenghea, Dumitru Tudor
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2015, 29 (08) : 1119 - 1123
  • [26] Influence of volume overload on cardiac biomarkers cTNT and NT-proBNP in chronic hemodialysis patients
    Sommerer, Claudia
    Heckele, Nadine
    Katus, Hugo A.
    Giannitsis, Evangelos
    Zeier, Martin
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 432 - 432
  • [27] NT-proBNP to Exclude cardiovascular Complications in Patients with Diabetes mellitus Type 2
    Resl, M.
    Huelsmann, M.
    Pacher, R.
    Luger, A.
    Clodi, M.
    WIENER KLINISCHE WOCHENSCHRIFT, 2013, 125 (17-18) : 559 - 559
  • [28] Nt-proBNP is increased in patients with severe obesity
    Fernandes, F
    Ramires, FJA
    Buck, P
    Rabelo, R
    Halpern, A
    Almeida, I
    Dantas, S
    Mady, C
    JOURNAL OF CARDIAC FAILURE, 2004, 10 (04) : S130 - S130
  • [29] NT-proBNP as a predictor of death and cardiovascular events in patients with type 2 diabetes
    Marcus Vinicius Bolivar Malachias
    Magnus Olof Wijkman
    Marcello Casaccia Bertoluci
    Diabetology & Metabolic Syndrome, 14
  • [30] Nt-proBNP in haemodialysis patients:: A preliminary study
    Trape, Jaume
    Perez, Alicia
    Naval, Isabel
    Escudero, Juan
    Comerma, Isabel
    Sans, Antonia
    Franquesa, Josefina
    Vidal, Carmen
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2008, 68 (05): : 415 - 420
12345